Toujeo
Payments companies reported to CMS as associated with Toujeo. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Toujeo, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Toujeo
These are the largest totals companies reported as associated with Toujeo. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Kevan Herold | New Haven, CT | Endocrinology, Diabetes & Metabolism | $71,982.68 |
| Marian Rewers | Aurora, CO | Pediatric Endocrinology | $39,444.64 |
| Kevin Pho | Nashua, NH | Internal Medicine | $38,375.00 |
| Steven Edelman | San Diego, CA | Internal Medicine | $31,900.04 |
| Emily Sims | Indianapolis, IN | Pediatric Endocrinology | $31,582.14 |
| Jeremy Pettus | San Diego, CA | Endocrinology, Diabetes & Metabolism | $23,428.79 |
| Kupper Wintergerst | Louisville, KY | Pediatric Endocrinology | $18,870.44 |
| Yehuda Handelsman | Tarzana, CA | Endocrinology, Diabetes & Metabolism | $18,759.42 |
| Gulliermo Umpierrez | Atlanta, GA | Endocrinology, Diabetes & Metabolism | $16,942.70 |
| Timothy Bailey | Escondido, CA | Endocrinology, Diabetes & Metabolism | $16,159.78 |
Prescribed Toujeo?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.